ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,287.28
      -0.37%
      US Tech 100
      18,278.80
      0.28%
      Dow Jones
      39,171.15
      -1.26%
      Brent Oil
      80.94
      -0.72%
      Bitcoin
      67,827.61
      -1.85%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Tourmaline Bio Inc (TRML)

      7. Tourmaline Bio Inc (TRML) News

      TRML

      Tourmaline Bio (TRML)

      Tourmaline Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TRML
      DateTimeSourceHeadlineSymbolCompany
      05/23/20247:10AMGlobeNewswire Inc.Tourmaline Bio to Present at the Jefferies Global Healthcare ConferenceNASDAQ:TRMLTourmaline Bio Inc
      05/16/20247:00AMGlobeNewswire Inc.Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY TrialNASDAQ:TRMLTourmaline Bio Inc
      05/13/20244:18PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRMLTourmaline Bio Inc
      05/13/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
      05/13/20247:00AMGlobeNewswire Inc.Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:TRMLTourmaline Bio Inc
      04/02/20247:00AMGlobeNewswire Inc.Avalo Therapeutics Appoints Biotech Leaders to Board of DirectorsNASDAQ:TRMLTourmaline Bio Inc
      03/19/20247:00AMGlobeNewswire Inc.Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:TRMLTourmaline Bio Inc
      02/27/20247:30AMGlobeNewswire Inc.Tourmaline Bio to Present at Upcoming Investor ConferencesNASDAQ:TRMLTourmaline Bio Inc
      02/14/20249:08PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TRMLTourmaline Bio Inc
      02/14/20248:51PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TRMLTourmaline Bio Inc
      02/09/20244:22PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TRMLTourmaline Bio Inc
      02/01/20248:00AMGlobeNewswire Inc.Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology ConferenceNASDAQ:TRMLTourmaline Bio Inc
      01/29/20244:01PMGlobeNewswire Inc.Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:TRMLTourmaline Bio Inc
      01/26/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
      01/26/20244:08PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRMLTourmaline Bio Inc
      01/25/20247:00AMGlobeNewswire Inc.Tourmaline Bio Announces Pricing of Public Offering of Common StockNASDAQ:TRMLTourmaline Bio Inc
      01/24/20249:20PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRMLTourmaline Bio Inc
      01/24/20245:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
      01/24/20244:05PMGlobeNewswire Inc.Tourmaline Bio Announces Proposed Public Offering of Common StockNASDAQ:TRMLTourmaline Bio Inc
      01/08/20249:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
      01/08/20247:00AMGlobeNewswire Inc.Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)NASDAQ:TRMLTourmaline Bio Inc
      12/15/20234:00PMGlobeNewswire Inc.Tourmaline Bio added to the NASDAQ Biotechnology IndexNASDAQ:TRMLTourmaline Bio Inc
      12/14/20238:27AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
      12/14/20237:30AMGlobeNewswire Inc.Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the BoardNASDAQ:TRMLTourmaline Bio Inc
      11/30/20238:25AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
      11/01/20238:00AMGlobeNewswire Inc.Tourmaline Bio to Present at Upcoming Investor ConferencesNASDAQ:TRMLTourmaline Bio Inc
      10/23/20238:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
      10/23/20238:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
      10/23/20238:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
      10/23/20238:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
       Showing the most relevant articles for your search:NASDAQ:TRML

      Your Recent History

      LSE
      43HD
      Municplty 1.35%
      Delayed Upgrade Clock